# ![@ApexOnco Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::3046218845.png) @ApexOnco ApexOnco

ApexOnco posts on X about $azn, $dsnky, $mrk, $bmy the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::3046218845/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3046218845/c:line/m:interactions.svg)

- [--] Month [---] -41%
- [--] Months [-------] -39%
- [--] Year [-------] -28%

### Mentions: [--] [#](/creator/twitter::3046218845/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3046218845/c:line/m:posts_active.svg)

- [--] Month [--] -73%
- [--] Months [--] -20%
- [--] Year [---] -9.20%

### Followers: [-----] [#](/creator/twitter::3046218845/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3046218845/c:line/m:followers.svg)

- [--] Month [-----] +0.44%
- [--] Months [-----] +8.10%
- [--] Year [-----] +23%

### CreatorRank: [---------] [#](/creator/twitter::3046218845/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::3046218845/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  63.73% [currencies](/list/currencies)  18.63% [cryptocurrencies](/list/cryptocurrencies)  6.86% [finance](/list/finance)  3.92% [technology brands](/list/technology-brands)  2.94%

**Social topic influence**
[$azn](/topic/$azn) 18.63%, [$dsnky](/topic/$dsnky) 11.76%, [$mrk](/topic/$mrk) #102, [$bmy](/topic/$bmy) 8.82%, [$jnj](/topic/$jnj) 7.84%, [$pfe](/topic/$pfe) 6.86%, [$rhhby](/topic/$rhhby) 6.86%, [$mkgaf](/topic/$mkgaf) 6.86%, [$incy](/topic/$incy) 6.86%, [$amgn](/topic/$amgn) 5.88%

**Top accounts mentioned or mentioned by**
[@jacobplieth](/creator/undefined) [@bymadeleinea](/creator/undefined) [@batirtzeareitio](/creator/undefined) [@spontonic](/creator/undefined) [@wearecbtn](/creator/undefined) [@fosterjb](/creator/undefined) [@neuroonc](/creator/undefined) [@merckgroup](/creator/undefined) [@frankri53999857](/creator/undefined) [@senefliveevents](/creator/undefined) [@kinatsofrim](/creator/undefined) [@bigchodu](/creator/undefined) [@timcarmichael3](/creator/undefined) [@jpzaragoza1](/creator/undefined) [@inshatters1](/creator/undefined)

**Top assets mentioned**
[AstraZeneca PLC (AZN)](/topic/$azn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Johnson & Johnson (JNJ)](/topic/$jnj) [Pfizer, Inc. (PFE)](/topic/$pfe) [Incyte Corporation (INCY)](/topic/$incy) [Amgen, Inc. (AMGN)](/topic/$amgn) [GSK plc (GSK)](/topic/$gsk) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Novartis AG (NVS)](/topic/$nvs) [Synthetify (SNY)](/topic/$sny) [One Cash (ONC)](/topic/$onc) [AbbVie Inc (ABBV)](/topic/$abbv) [Janux Therapeutics, Inc. (JANX)](/topic/$janx) [Moderna Inc (MRNA)](/topic/$mrna) [Arvinas, Inc (ARVN)](/topic/$arvn) [Bolt Biotherapeutics, Inc. (BOLT)](/topic/$bolt) [Exelixis Inc (EXEL)](/topic/$exel) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [Arcus Biosciences, Inc. (RCUS)](/topic/$rcus) [Cullinan Management, Inc. (CGEM)](/topic/$cgem) [Legend Biotech Corp (LEGN)](/topic/$legn) [ArriVent BioPharma, Inc.  (AVBP)](/topic/$avbp) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [ADC Therapeutics SA (ADCT)](/topic/$adct) [ImmunityBio, Inc. Common Stock (IBRX)](/topic/$ibrx) [CG Oncology, Inc.  (CGON)](/topic/$cgon) [Turnstone Biologics Corp. (TSBX)](/topic/$tsbx) [Day One Biopharmaceuticals, Inc. (DAWN)](/topic/$dawn) [Immunome, Inc. (IMNM)](/topic/$imnm) [Bluefin (BLUE)](/topic/$blue) [Achilles Therapeutics Plc (ACHL)](/topic/$achl) [Caribou Biosciences, Inc. (CRBU)](/topic/$crbu) [iTeos Therapeutics, Inc. (ITOS)](/topic/$itos) [Nurix Therapeutics, Inc. (NRIX)](/topic/$nrix) [Eli Lilly and Company (LLY)](/topic/$lly) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Black Diamond Therapeutics Inc. (BDTX)](/topic/$bdtx) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Olema Pharmaceuticals, Inc. (OLMA)](/topic/$olma) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$MRK Keytrudas 25th EU green light https://www.oncologypipeline.com/apexonco/keytrudas-25th-eu-green-light https://www.oncologypipeline.com/apexonco/keytrudas-25th-eu-green-light"  
[X Link](https://x.com/anyuser/status/1713918852713570793)  2023-10-16T14:04Z [----] followers, [----] engagements


"Another setback for Opdualag's post-melanoma plan $BMY $REGN $MRK https://www.oncologypipeline.com/apexonco/another-setback-opdualags-post-melanoma-plan https://www.oncologypipeline.com/apexonco/another-setback-opdualags-post-melanoma-plan"  
[X Link](https://x.com/anyuser/status/1736743503042851083)  2023-12-18T13:41Z [----] followers, [----] engagements


"$CTMX has a tox wobble $JANX https://www.oncologypipeline.com/apexonco/node/1513 https://www.oncologypipeline.com/apexonco/node/1513"  
[X Link](https://x.com/ApexOnco/status/1955658987560751442)  2025-08-13T15:53Z [----] followers, [----] engagements


"A mystery $MRNA asset hits the clinic https://www.oncologypipeline.com/apexonco/node/1524 https://www.oncologypipeline.com/apexonco/node/1524"  
[X Link](https://x.com/ApexOnco/status/1958815699998011707)  2025-08-22T08:57Z [----] followers, [----] engagements


"$MGNX faces new competition. Plus other first-in-human trial initiations https://www.oncologypipeline.com/apexonco/macrogenics-faces-new-competition https://www.oncologypipeline.com/apexonco/macrogenics-faces-new-competition"  
[X Link](https://x.com/ApexOnco/status/1962489464371970405)  2025-09-01T12:15Z [----] followers, [----] engagements


"#WCLC25 Backing for $BMY's pivotal HER3 conjugate moves https://www.oncologypipeline.com/apexonco/world-lung-2025-backing-bristols-pivotal-her3-conjugate-moves https://www.oncologypipeline.com/apexonco/world-lung-2025-backing-bristols-pivotal-her3-conjugate-moves"  
[X Link](https://x.com/ApexOnco/status/1964425354468106733)  2025-09-06T20:27Z [----] followers, [----] engagements


"#WCLC25 crossing curves in lung cancer - $AZN Flaura2 vs $JNJ Mariposa https://www.oncologypipeline.com/apexonco/world-lung-2025-crossing-curves-lung-cancer https://www.oncologypipeline.com/apexonco/world-lung-2025-crossing-curves-lung-cancer"  
[X Link](https://x.com/ApexOnco/status/1965039473491685819)  2025-09-08T13:08Z [----] followers, [----] engagements


"$AZN and $JNJ tussle over first-line NSCLC https://www.oncologypipeline.com/apexonco/node/1578 https://www.oncologypipeline.com/apexonco/node/1578"  
[X Link](https://x.com/ApexOnco/status/1968236012175523960)  2025-09-17T08:50Z [----] followers, [----] engagements


"Neither $ARVN nor $PFE now wants vepdegestrant https://www.oncologypipeline.com/apexonco/node/1584 https://www.oncologypipeline.com/apexonco/node/1584"  
[X Link](https://x.com/ApexOnco/status/1968635655933599874)  2025-09-18T11:18Z [----] followers, [----] engagements


"Different problem same result for $BOLT https://www.oncologypipeline.com/apexonco/different-problem-same-result-bolt https://www.oncologypipeline.com/apexonco/different-problem-same-result-bolt"  
[X Link](https://x.com/ApexOnco/status/1973734818648342983)  2025-10-02T13:00Z [----] followers, [----] engagements


"$ALPMF pays $175m for a cautious Xtandi insurance plan https://www.oncologypipeline.com/apexonco/astellas-pays-175m-cautious-xtandi-insurance-plan https://www.oncologypipeline.com/apexonco/astellas-pays-175m-cautious-xtandi-insurance-plan"  
[X Link](https://x.com/ApexOnco/status/1725149109953122317)  2023-11-16T13:49Z [----] followers, [----] engagements


"$BMY shows its alnuctamab hand https://www.oncologypipeline.com/apexonco/node/429 https://www.oncologypipeline.com/apexonco/node/429"  
[X Link](https://x.com/ApexOnco/status/1754462671565381772)  2024-02-05T11:11Z [----] followers, 17.7K engagements


"$AZN takes Steap2 Car-T AZD0754 into human trials. and other first-in-human study initiations $INKA $CTMX $XNCR https://www.oncologypipeline.com/apexonco/astra-takes-steap2-human-trials https://www.oncologypipeline.com/apexonco/astra-takes-steap2-human-trials"  
[X Link](https://x.com/ApexOnco/status/1762965686995808266)  2024-02-28T22:19Z [----] followers, [----] engagements


"After $ALPMF zolbetuximab investors look for a Claudin18.2 encore https://www.oncologypipeline.com/apexonco/node/516 https://www.oncologypipeline.com/apexonco/node/516"  
[X Link](https://x.com/ApexOnco/status/1772677451463696572)  2024-03-26T17:30Z [----] followers, 22K engagements


"$BNTX & Dualitybio branch out vs $DSNKY $AZN Enhertu https://www.oncologypipeline.com/apexonco/biontech-and-dualitybio-branch-out https://www.oncologypipeline.com/apexonco/biontech-and-dualitybio-branch-out"  
[X Link](https://x.com/ApexOnco/status/1775854248401526966)  2024-04-04T11:53Z [----] followers, [----] engagements


"Another Zynlonta shift $ADCT https://www.oncologypipeline.com/apexonco/another-zynlonta-shift https://www.oncologypipeline.com/apexonco/another-zynlonta-shift"  
[X Link](https://x.com/ApexOnco/status/1788229164425703635)  2024-05-08T15:27Z [----] followers, [----] engagements


"$GMAB $BNTX acasunlimab impresses on overall survival #ASCO24 https://www.oncologypipeline.com/apexonco/asco-2024-acasunlimab-impresses-overall-survival https://www.oncologypipeline.com/apexonco/asco-2024-acasunlimab-impresses-overall-survival"  
[X Link](https://x.com/ApexOnco/status/1797371539643339096)  2024-06-02T20:55Z [----] followers, [----] engagements


"$RHHBY USP1 lives on for now #ASCO24 $EXEL $TNGX https://www.oncologypipeline.com/apexonco/asco-2024-usp1-lives-now https://www.oncologypipeline.com/apexonco/asco-2024-usp1-lives-now"  
[X Link](https://x.com/ApexOnco/status/1797371738163991033)  2024-06-02T20:56Z [----] followers, [----] engagements


"Another private UK biotech just going into phase 1: Duke Street Bio's Parp1 inhibitor DSB2455 $AZN $MKGAF https://www.clinicaltrials.gov/study/NCT06458712 https://www.clinicaltrials.gov/study/NCT06458712"  
[X Link](https://x.com/ApexOnco/status/1803371735187616228)  2024-06-19T10:18Z [----] followers, [----] engagements


"$ARGX steps back from subcutaneous Vyvgart https://www.oncologypipeline.com/apexonco/argenx-steps-back-subcutaneous-vyvgart https://www.oncologypipeline.com/apexonco/argenx-steps-back-subcutaneous-vyvgart"  
[X Link](https://x.com/ApexOnco/status/1816899896223433018)  2024-07-26T18:14Z [----] followers, [----] engagements


"After yesterday's acasunlimab setback what other $BNTX $GMAB bispecifics could be at risk Updated story via @ByMadeleineA - https://www.oncologypipeline.com/apexonco/another-vote-no-confidence-co-stimulated-bispecifics https://www.oncologypipeline.com/apexonco/another-vote-no-confidence-co-stimulated-bispecifics"  
[X Link](https://x.com/ApexOnco/status/1820813621531652321)  2024-08-06T13:26Z [----] followers, [----] engagements


"$INCY Monjuvi scores a qualified indolent lymphoma success https://www.oncologypipeline.com/apexonco/monjuvi-scores-qualified-indolent-lymphoma-success https://www.oncologypipeline.com/apexonco/monjuvi-scores-qualified-indolent-lymphoma-success"  
[X Link](https://x.com/ApexOnco/status/1824506910550396948)  2024-08-16T18:01Z [----] followers, [---] engagements


"Catalyst tracker: Octobers upcoming events in oncology https://www.oncologypipeline.com/apexonco/month-ahead-octobers-upcoming-events https://www.oncologypipeline.com/apexonco/month-ahead-octobers-upcoming-events"  
[X Link](https://x.com/ApexOnco/status/1841474649260982415)  2024-10-02T13:45Z [----] followers, [----] engagements


"$JNJ ramps up its bladder cancer battle. @ByMadeleineA interview from #ESMO24 $IBRX $CGON $AZN $MRK https://www.oncologypipeline.com/apexonco/jj-ramps-its-bladder-cancer-battle https://www.oncologypipeline.com/apexonco/jj-ramps-its-bladder-cancer-battle"  
[X Link](https://x.com/ApexOnco/status/1842186314235740172)  2024-10-04T12:53Z [----] followers, [----] engagements


"$IPN.PA low-key #ESMO24 Tazverik poster casts doubt on $PFE mevrometostat plan in prostate cancer https://www.oncologypipeline.com/apexonco/ipsen-casts-doubt-pfizers-prostate-plan https://www.oncologypipeline.com/apexonco/ipsen-casts-doubt-pfizers-prostate-plan"  
[X Link](https://x.com/ApexOnco/status/1843260079694586022)  2024-10-07T12:00Z [----] followers, [----] engagements


"$GMAB presses on with acasunlimab https://www.oncologypipeline.com/apexonco/genmab-presses-acasunlimab https://www.oncologypipeline.com/apexonco/genmab-presses-acasunlimab"  
[X Link](https://x.com/ApexOnco/status/1845816070872924169)  2024-10-14T13:16Z [----] followers, [----] engagements


"No easy ride for $TSBX https://www.oncologypipeline.com/apexonco/node/898 https://www.oncologypipeline.com/apexonco/node/898"  
[X Link](https://x.com/ApexOnco/status/1845816191668904299)  2024-10-14T13:17Z [----] followers, [---] engagements


"$MKGAF anti-GD2 ADC M3554 now in a phase [--] trial https://clinicaltrials.gov/study/NCT06641908 @wearecbtn @FosterJb @NeuroOnc For the first time there is now a GD2-targeting ADC apparently in the clinic by @merckgroup #AACR2024 - M3554 - described as a "clinical" GD2-antibody with an inactivated Fc carrying Exatecan as a payload. Optimized for a large bystander killing effect https://t.co/doFT9Y7XeE https://clinicaltrials.gov/study/NCT06641908 @wearecbtn @FosterJb @NeuroOnc For the first time there is now a GD2-targeting ADC apparently in the clinic by @merckgroup #AACR2024 - M3554 - described"  
[X Link](https://x.com/ApexOnco/status/1849493762742849807)  2024-10-24T16:50Z [----] followers, [----] engagements


"No S.O.S. for Bayer's SOS1 plus first-in-human trial initiations from $MKGAF Tubulis & $JNJ https://www.oncologypipeline.com/apexonco/node/929 https://www.oncologypipeline.com/apexonco/node/929"  
[X Link](https://x.com/ApexOnco/status/1851984131728572469)  2024-10-31T13:46Z [----] followers, [----] engagements


"$MKGAF gets a rare cancer win $DSNKY https://www.oncologypipeline.com/apexonco/node/949 https://www.oncologypipeline.com/apexonco/node/949"  
[X Link](https://x.com/ApexOnco/status/1856396736412991503)  2024-11-12T18:00Z [----] followers, [---] engagements


"Nerviano becomes a targeted PARP player with cast-offs from $MKGAF & Ribon https://www.oncologypipeline.com/apexonco/nerviano-becomes-targeted-parp-player https://www.oncologypipeline.com/apexonco/nerviano-becomes-targeted-parp-player"  
[X Link](https://x.com/ApexOnco/status/1861779437957587156)  2024-11-27T14:29Z [----] followers, [----] engagements


"$MRK RORs into phase [--] $IPN $ONCT https://www.oncologypipeline.com/apexonco/node/1000 https://www.oncologypipeline.com/apexonco/node/1000"  
[X Link](https://x.com/ApexOnco/status/1865104709213987018)  2024-12-06T18:43Z [----] followers, [----] engagements


"Recent first-in-human trial initiations: [--] Kelun ADCs (one partnered with $MRK) [--] actinium-labelled radioTx (one ex RayzeBio $BMY) Akeso's HER3 possible CDK2i from $NVS & $MGNX's second try at Adam9: https://www.oncologypipeline.com/apexonco/conjugates-enter-their-first-clinical-trials https://www.oncologypipeline.com/apexonco/conjugates-enter-their-first-clinical-trials"  
[X Link](https://x.com/ApexOnco/status/1869397507215851839)  2024-12-18T15:01Z [----] followers, [----] engagements


"Biocytogen PTK7 in vivo Car-T and other first-in-human trial initiations $MDGEF $BNTX $DAWN https://www.oncologypipeline.com/apexonco/biocytogen-and-ptk7-remain-hot https://www.oncologypipeline.com/apexonco/biocytogen-and-ptk7-remain-hot"  
[X Link](https://x.com/ApexOnco/status/1877324027489931431)  2025-01-09T11:58Z [----] followers, [----] engagements


"$SWTX gets an early second approval $MKGAF $AZN https://www.oncologypipeline.com/apexonco/springworks-gets-early-second-approval https://www.oncologypipeline.com/apexonco/springworks-gets-early-second-approval"  
[X Link](https://x.com/ApexOnco/status/1889685307953479867)  2025-02-12T14:37Z [----] followers, [----] engagements


"$AZN $DSNKY Enhertu goes pivotal in ovarian https://www.oncologypipeline.com/apexonco/enhertu-goes-pivotal-ovarian https://www.oncologypipeline.com/apexonco/enhertu-goes-pivotal-ovarian"  
[X Link](https://x.com/ApexOnco/status/1889685402971165032)  2025-02-12T14:38Z [----] followers, [---] engagements


"Tightening the $BOLT on a questionable strategy https://www.oncologypipeline.com/apexonco/tightening-bolt-questionable-strategy https://www.oncologypipeline.com/apexonco/tightening-bolt-questionable-strategy"  
[X Link](https://x.com/ApexOnco/status/1889685565307494432)  2025-02-12T14:38Z [----] followers, [----] engagements


"$PFE eyes broader Talzenna use #GU25 https://www.oncologypipeline.com/apexonco/asco-gu-pfizer-eyes-broader-talzenna-use https://www.oncologypipeline.com/apexonco/asco-gu-pfizer-eyes-broader-talzenna-use"  
[X Link](https://x.com/ApexOnco/status/1890053736984412562)  2025-02-13T15:01Z [----] followers, [----] engagements


"$GLPG tightens its focus https://www.oncologypipeline.com/apexonco/galapagos-tightens-its-focus https://www.oncologypipeline.com/apexonco/galapagos-tightens-its-focus"  
[X Link](https://x.com/ApexOnco/status/1890458006631944407)  2025-02-14T17:48Z [----] followers, [---] engagements


"$RCUS HIF focus turns to survival $MRK https://www.oncologypipeline.com/apexonco/asco-gu-arcuss-hifa-focus-turns-survival https://www.oncologypipeline.com/apexonco/asco-gu-arcuss-hifa-focus-turns-survival"  
[X Link](https://x.com/ApexOnco/status/1891502434658197568)  2025-02-17T14:58Z [----] followers, [----] engagements


"Ono takes on $DSNKY in tenosynovial giant cell tumour https://www.oncologypipeline.com/apexonco/ono-takes-daiichi-tenosynovial-giant-cell-tumour https://www.oncologypipeline.com/apexonco/ono-takes-daiichi-tenosynovial-giant-cell-tumour"  
[X Link](https://x.com/ApexOnco/status/1891502579244298408)  2025-02-17T14:58Z [----] followers, [----] engagements


"More first-in-human clinical trial starts: Kyowa in Tim-3 $TNGX with its third PRMT5 Domain in CCR8 and $INCY with possibly its second KRAS G12D https://www.oncologypipeline.com/apexonco/node/1132 https://www.oncologypipeline.com/apexonco/node/1132"  
[X Link](https://x.com/ApexOnco/status/1892133485940228277)  2025-02-19T08:45Z [----] followers, [---] engagements


"Low-key interest in ROR1 continues with Radiance picking up CSPC rights for $15m $IPN.PA $STRO $ZLAB $IMNM $ANTL https://www.oncologypipeline.com/apexonco/node/1133 https://www.oncologypipeline.com/apexonco/node/1133"  
[X Link](https://x.com/ApexOnco/status/1892184270531178791)  2025-02-19T12:07Z [----] followers, [----] engagements


"Another strike against Cabometyx $EXEL $BMY #GU25 https://www.oncologypipeline.com/apexonco/node/1137 https://www.oncologypipeline.com/apexonco/node/1137"  
[X Link](https://x.com/ApexOnco/status/1892596457460367463)  2025-02-20T15:25Z [----] followers, [----] engagements


"$BLUE caged by private equity https://www.oncologypipeline.com/apexonco/node/1140 https://www.oncologypipeline.com/apexonco/node/1140"  
[X Link](https://x.com/ApexOnco/status/1894041420882641282)  2025-02-24T15:07Z [----] followers, [----] engagements


"$MRK takes on $DSNKY & $AZN again in breast cancer https://www.oncologypipeline.com/apexonco/node/1145 https://www.oncologypipeline.com/apexonco/node/1145"  
[X Link](https://x.com/ApexOnco/status/1894683561069834437)  2025-02-26T09:38Z [----] followers, [----] engagements


"A pivotal push from $BGNE https://www.oncologypipeline.com/apexonco/node/1154 https://www.oncologypipeline.com/apexonco/node/1154"  
[X Link](https://x.com/ApexOnco/status/1896553876016509009)  2025-03-03T13:30Z [----] followers, [----] engagements


"Hello $BBOT farewell $SYRS & $ACHL https://www.oncologypipeline.com/apexonco/node/1156 https://www.oncologypipeline.com/apexonco/node/1156"  
[X Link](https://x.com/ApexOnco/status/1896554156133167110)  2025-03-03T13:32Z [----] followers, [----] engagements


"Catalyst Make or break time for $CRBU https://www.oncologypipeline.com/apexonco/make-or-break-time-caribou https://www.oncologypipeline.com/apexonco/make-or-break-time-caribou"  
[X Link](https://x.com/ApexOnco/status/1903039567143281112)  2025-03-21T11:02Z [----] followers, [----] engagements


"Another $SNY setback for $IPHA https://www.oncologypipeline.com/apexonco/node/1216 https://www.oncologypipeline.com/apexonco/node/1216"  
[X Link](https://x.com/ApexOnco/status/1905239379674579001)  2025-03-27T12:44Z [----] followers, [----] engagements


"$MKGAF makes $SWTX holder squirm https://www.oncologypipeline.com/apexonco/node/1218 https://www.oncologypipeline.com/apexonco/node/1218"  
[X Link](https://x.com/ApexOnco/status/1905641346724995133)  2025-03-28T15:21Z [----] followers, [---] engagements


"$BGNE $ONC bows out of Tigit $AZN $ITOS $GSK $RHHBY $RCUS $GILD $MRK https://www.oncologypipeline.com/apexonco/beigene-bows-out-tigit https://www.oncologypipeline.com/apexonco/beigene-bows-out-tigit"  
[X Link](https://x.com/ApexOnco/status/1907802291186307575)  2025-04-03T14:28Z [----] followers, [----] engagements


"$DSNKY $AZN Enhertu could fill a gastric hole https://www.oncologypipeline.com/apexonco/enhertu-could-fill-gastric-hole https://www.oncologypipeline.com/apexonco/enhertu-could-fill-gastric-hole"  
[X Link](https://x.com/ApexOnco/status/1907802367782711550)  2025-04-03T14:28Z [----] followers, [---] engagements


"1st-line SCAC win swings it for Zynyz $INCY $MGNX https://www.oncologypipeline.com/apexonco/node/1326 https://www.oncologypipeline.com/apexonco/node/1326"  
[X Link](https://x.com/ApexOnco/status/1923416344952783151)  2025-05-16T16:32Z [----] followers, [----] engagements


"$BGNE's head-to-head test advances $NRIX $LLY https://www.oncologypipeline.com/apexonco/node/1328 https://www.oncologypipeline.com/apexonco/node/1328"  
[X Link](https://x.com/ApexOnco/status/1924456999317557651)  2025-05-19T13:27Z [----] followers, [----] engagements


"Avistones Met challenge $JNJ Dizal $CGEM https://www.oncologypipeline.com/apexonco/node/1329 https://www.oncologypipeline.com/apexonco/node/1329"  
[X Link](https://x.com/ApexOnco/status/1924457590001418662)  2025-05-19T13:30Z [----] followers, [----] engagements


"$JNJ gets a smouldering endorsement https://www.oncologypipeline.com/apexonco/node/1335 https://www.oncologypipeline.com/apexonco/node/1335"  
[X Link](https://x.com/ApexOnco/status/1925157395379945574)  2025-05-21T11:51Z [----] followers, 11.9K engagements


"$GILD Trodelvy trumps $AZN $DSNKY Datroway again https://www.oncologypipeline.com/apexonco/node/1342 https://www.oncologypipeline.com/apexonco/node/1342"  
[X Link](https://x.com/ApexOnco/status/1925934245987381682)  2025-05-23T15:18Z [----] followers, [----] engagements


"A 3SBio bispecific encore plus [--] new in vivo Car-T therapies appear in new first-in-human trial initiations $LEGN https://www.oncologypipeline.com/apexonco/node/1377/ https://www.oncologypipeline.com/apexonco/node/1377/"  
[X Link](https://x.com/ApexOnco/status/1931001250922824028)  2025-06-06T14:52Z [----] followers, [----] engagements


"$KURA joins the pivotal menin push $SNDX $JNJ https://www.oncologypipeline.com/apexonco/node/1381 https://www.oncologypipeline.com/apexonco/node/1381"  
[X Link](https://x.com/ApexOnco/status/1932163672153239580)  2025-06-09T19:51Z [----] followers, [----] engagements


"Biotech catalyst: after $BMPC takeover by $SNY comes the big test for $COGT https://www.oncologypipeline.com/apexonco/node/1405 https://www.oncologypipeline.com/apexonco/node/1405"  
[X Link](https://x.com/ApexOnco/status/1936134309892526546)  2025-06-20T18:49Z [----] followers, [----] engagements


"$AVBP goes Further into PACC mutations $BDTX https://www.oncologypipeline.com/apexonco/node/1409/ https://www.oncologypipeline.com/apexonco/node/1409/"  
[X Link](https://x.com/ApexOnco/status/1937457618819387813)  2025-06-24T10:27Z [----] followers, [----] engagements


"$ONC $BGNE also needs B7-H4 biomarkers https://www.oncologypipeline.com/apexonco/beone-also-needs-b7-h4-biomarkers https://www.oncologypipeline.com/apexonco/beone-also-needs-b7-h4-biomarkers"  
[X Link](https://x.com/ApexOnco/status/1939695875330383916)  2025-06-30T14:41Z [----] followers, [---] engagements


"$AZN speeds puxitatug samrotecan into pivotal development $GSK $MRSN $ONC $BGNE https://www.oncologypipeline.com/apexonco/node/1429 https://www.oncologypipeline.com/apexonco/node/1429"  
[X Link](https://x.com/ApexOnco/status/1940410343974748188)  2025-07-02T14:00Z [----] followers, [----] engagements


"Latest first-in-human trial initiations include ADCs against CDH17 & CDH6 $AVBP $AZN $PVMP https://www.oncologypipeline.com/apexonco/node/1471 https://www.oncologypipeline.com/apexonco/node/1471"  
[X Link](https://x.com/ApexOnco/status/1948017372859695112)  2025-07-23T13:48Z [----] followers, [---] engagements


"$GMAB $ABBV Epkinly bucks the delay trend $RHHBY $REGN https://www.oncologypipeline.com/apexonco/node/1504 https://www.oncologypipeline.com/apexonco/node/1504"  
[X Link](https://x.com/ApexOnco/status/1954979910008676615)  2025-08-11T18:55Z [----] followers, [---] engagements


"Tricky mechanisms fall by the wayside $GILD $STRO $IPN.PA https://www.oncologypipeline.com/apexonco/node/1505 https://www.oncologypipeline.com/apexonco/node/1505"  
[X Link](https://x.com/ApexOnco/status/1954980188858544188)  2025-08-11T18:56Z [----] followers, [----] engagements


"Bladder cancer next for $DSNKY $AZN Datroway https://www.oncologypipeline.com/apexonco/bladder-cancer-next-datroway https://www.oncologypipeline.com/apexonco/bladder-cancer-next-datroway"  
[X Link](https://x.com/ApexOnco/status/1958815825411883374)  2025-08-22T08:57Z [----] followers, [---] engagements


"$IDYA challenges $ZLAB at #WCLC25 $AMGN https://www.oncologypipeline.com/apexonco/world-lung-2025-ideaya-challenges-zai-lab https://www.oncologypipeline.com/apexonco/world-lung-2025-ideaya-challenges-zai-lab"  
[X Link](https://x.com/ApexOnco/status/1965039621848633828)  2025-09-08T13:08Z [----] followers, [----] engagements


"Hopes dim for $IPHA NK-cell engagers https://www.oncologypipeline.com/apexonco/node/1581 https://www.oncologypipeline.com/apexonco/node/1581"  
[X Link](https://x.com/ApexOnco/status/1968287899633529262)  2025-09-17T12:16Z [----] followers, [----] engagements


"$RHHBY pushes a novel myeloma target $LEGN $MRNA https://www.oncologypipeline.com/apexonco/node/1591 https://www.oncologypipeline.com/apexonco/node/1591"  
[X Link](https://x.com/ApexOnco/status/1970768778876408136)  2025-09-24T08:34Z [----] followers, [----] engagements


"#ESMO25 preview a bemarituzumab reckoning approaches $AMGN $MRK $DSNKY $AZN $SMMT $NVS $IMTX $ZLAB $PFE $ALPMF https://www.oncologypipeline.com/apexonco/node/1597 https://www.oncologypipeline.com/apexonco/node/1597"  
[X Link](https://x.com/ApexOnco/status/1971157730334548323)  2025-09-25T10:19Z [----] followers, [----] engagements


"$TAK cancer prospects dim further https://www.oncologypipeline.com/apexonco/takedas-cancer-prospects-dim-further https://www.oncologypipeline.com/apexonco/takedas-cancer-prospects-dim-further"  
[X Link](https://x.com/ApexOnco/status/1973734720858161663)  2025-10-02T13:00Z [----] followers, [----] engagements


"$PFE fuels Cartography push into LY6G6D where $RHHBY failed https://www.oncologypipeline.com/apexonco/node/1623 https://www.oncologypipeline.com/apexonco/node/1623"  
[X Link](https://x.com/ApexOnco/status/1974106767954227376)  2025-10-03T13:38Z [----] followers, [---] engagements


"$AZN & $DSNKY keep abreast of $GILD #ESMO25 https://www.oncologypipeline.com/apexonco/node/1624/ https://www.oncologypipeline.com/apexonco/node/1624/"  
[X Link](https://x.com/ApexOnco/status/1975206008286003337)  2025-10-06T14:26Z [----] followers, [----] engagements


"$BMY is next into in vivo Car-T https://www.oncologypipeline.com/apexonco/node/1635 https://www.oncologypipeline.com/apexonco/node/1635"  
[X Link](https://x.com/ApexOnco/status/1976653989396820237)  2025-10-10T14:20Z [----] followers, [----] engagements


"#ESMO25 has $RHHBY giredestrant done enough for an all-comers label $OLMA $ARVN https://www.oncologypipeline.com/apexonco/node/1656/ https://www.oncologypipeline.com/apexonco/node/1656/"  
[X Link](https://x.com/ApexOnco/status/1979590099596873904)  2025-10-18T16:47Z [----] followers, [---] engagements


"$DSNKY $AZN Datroway and $GILD Trodelvy face off in triple-negative breast cancer #ESMO25 https://www.oncologypipeline.com/apexonco/esmo-2025-datroway-and-trodelvy-face-triple-negative-breast https://www.oncologypipeline.com/apexonco/esmo-2025-datroway-and-trodelvy-face-triple-negative-breast"  
[X Link](https://x.com/ApexOnco/status/1979897049358512441)  2025-10-19T13:06Z [----] followers, [---] engagements


"$MRK & $DSNKY Rejoice over raludotatug deruxtecan #ESMO25 #ESMO25 https://www.oncologypipeline.com/apexonco/node/1669 https://www.oncologypipeline.com/apexonco/node/1669"  
[X Link](https://x.com/ApexOnco/status/1980223873959514336)  2025-10-20T10:45Z [----] followers, [----] engagements


"$SNY takes aim at $NVS Lutathera while $CATX disappoints again #ESMO25 https://www.oncologypipeline.com/apexonco/node/1672 https://www.oncologypipeline.com/apexonco/node/1672"  
[X Link](https://x.com/ApexOnco/status/1981013448835404147)  2025-10-22T15:03Z [----] followers, [----] engagements


"$AMGN $ZLAB bemarituzumab fails to convince #ESMO25 https://www.oncologypipeline.com/apexonco/node/1671 https://www.oncologypipeline.com/apexonco/node/1671"  
[X Link](https://x.com/ApexOnco/status/1981013567160877090)  2025-10-22T15:03Z [----] followers, [---] engagements


"$IPN.PA sees a future in gammadelta T cells https://www.oncologypipeline.com/apexonco/ipsen-sees-future-gammadelta-t-cells https://www.oncologypipeline.com/apexonco/ipsen-sees-future-gammadelta-t-cells"  
[X Link](https://x.com/ApexOnco/status/1981013903258820667)  2025-10-22T15:04Z [----] followers, [---] engagements


"$INCY impresses in KRAS G12D $VSTM #ESMO25 https://www.oncologypipeline.com/apexonco/esmo-2025-incyte-impresses-kras-g12d https://www.oncologypipeline.com/apexonco/esmo-2025-incyte-impresses-kras-g12d"  
[X Link](https://x.com/ApexOnco/status/1981014051716297102)  2025-10-22T15:05Z [----] followers, [---] engagements


"$RVMD hints at post-KRAS promise at #Targets25 https://www.oncologypipeline.com/apexonco/triple-meeting-2025-revolution-hints-post-kras-promise https://www.oncologypipeline.com/apexonco/triple-meeting-2025-revolution-hints-post-kras-promise"  
[X Link](https://x.com/ApexOnco/status/1981650343743148347)  2025-10-24T09:13Z [----] followers, [---] engagements


"$TNGX waltzes towards phase [--] with vopimetostat $BMY https://www.oncologypipeline.com/apexonco/node/1679 https://www.oncologypipeline.com/apexonco/node/1679"  
[X Link](https://x.com/ApexOnco/status/1981650775764877518)  2025-10-24T09:15Z [----] followers, 24.1K engagements


"$ZLAB discloses pivotal DLL3 plans going head to head vs Imdelltra #Targets25 $AMGN https://www.oncologypipeline.com/apexonco/node/1677 https://www.oncologypipeline.com/apexonco/node/1677"  
[X Link](https://x.com/ApexOnco/status/1981708640974500092)  2025-10-24T13:05Z [----] followers, [----] engagements


"Blenrep's half-way win sends $GSK -5% https://www.oncologypipeline.com/apexonco/node/1682 https://www.oncologypipeline.com/apexonco/node/1682"  
[X Link](https://x.com/ApexOnco/status/1981738603106509105)  2025-10-24T15:04Z [----] followers, [----] engagements


"FDA red and green lights: October [----] $JAZZ $GSK $REGN $SNDX $KURA https://www.oncologypipeline.com/apexonco/node/1699 https://www.oncologypipeline.com/apexonco/node/1699"  
[X Link](https://x.com/ApexOnco/status/1985362090047992138)  2025-11-03T15:03Z [----] followers, [---] engagements


"$INCY Incyte gets a $PRLD insurance policy https://www.oncologypipeline.com/apexonco/incyte-gets-prelude-insurance-policy https://www.oncologypipeline.com/apexonco/incyte-gets-prelude-insurance-policy"  
[X Link](https://x.com/ApexOnco/status/1985997913835860196)  2025-11-05T09:09Z [----] followers, 17.2K engagements


"Lorikeet fails to fly for $MGNX https://www.oncologypipeline.com/apexonco/node/1720 https://www.oncologypipeline.com/apexonco/node/1720"  
[X Link](https://x.com/ApexOnco/status/1988963459732836697)  2025-11-13T13:33Z [----] followers, [----] engagements


"$KURA gets a safety edge over $SNDX https://www.oncologypipeline.com/apexonco/node/1725 https://www.oncologypipeline.com/apexonco/node/1725"  
[X Link](https://x.com/ApexOnco/status/1989010119313731588)  2025-11-13T16:39Z [----] followers, [----] engagements


"$PFE speeds ahead with PD-1 x VEGF bispecific development $BNTX $BMY $SMMT https://www.oncologypipeline.com/apexonco/node/1727 https://www.oncologypipeline.com/apexonco/node/1727"  
[X Link](https://x.com/ApexOnco/status/1989363080137146835)  2025-11-14T16:01Z [----] followers, [---] engagements


"$AMGN goes pivotal with subcutaneous Blincyto https://www.oncologypipeline.com/apexonco/node/1729 https://www.oncologypipeline.com/apexonco/node/1729"  
[X Link](https://x.com/ApexOnco/status/1990445158652162366)  2025-11-17T15:41Z [----] followers, [---] engagements


"$GSK buys into myeloid cell engagers https://www.oncologypipeline.com/apexonco/node/1738 https://www.oncologypipeline.com/apexonco/node/1738"  
[X Link](https://x.com/ApexOnco/status/1991149766877589649)  2025-11-19T14:21Z [----] followers, 11.6K engagements


"The month ahead: Decembers upcoming catalysts $JANX $BMY $INCY $AMGN https://www.oncologypipeline.com/apexonco/node/1753 https://www.oncologypipeline.com/apexonco/node/1753"  
[X Link](https://x.com/ApexOnco/status/1994062105691947169)  2025-11-27T15:13Z [----] followers, [----] engagements


"Junshi is next with a subcutaneous PD-1 $MRK $PFE $BMY $RHHBY $CHRS https://www.oncologypipeline.com/apexonco/node/1752 https://www.oncologypipeline.com/apexonco/node/1752"  
[X Link](https://x.com/ApexOnco/status/1994062365373944033)  2025-11-27T15:14Z [----] followers, [----] engagements


"HengRui goes pivotal in KRAS G12D $RVMD $VSTM $ALPMF $INCY https://www.oncologypipeline.com/apexonco/node/1757 https://www.oncologypipeline.com/apexonco/node/1757"  
[X Link](https://x.com/ApexOnco/status/1994310343997218864)  2025-11-28T07:40Z [----] followers, [----] engagements


"$CRBP eyes a Nectin-4 pivotal first https://www.oncologypipeline.com/apexonco/node/1756 https://www.oncologypipeline.com/apexonco/node/1756"  
[X Link](https://x.com/ApexOnco/status/1994310440902439321)  2025-11-28T07:40Z [----] followers, [----] engagements


"$JNJ tries to outdo Tecvayli https://www.oncologypipeline.com/apexonco/node/1764 https://www.oncologypipeline.com/apexonco/node/1764"  
[X Link](https://x.com/ApexOnco/status/1996260375390806164)  2025-12-03T16:48Z [----] followers, [---] engagements


"Kelonia gets another response #ASH25 $AZN $ABBV https://www.oncologypipeline.com/apexonco/ash-2025-kelonia-gets-another-response https://www.oncologypipeline.com/apexonco/ash-2025-kelonia-gets-another-response"  
[X Link](https://x.com/ApexOnco/status/1998400864864591967)  2025-12-09T14:34Z [----] followers, [----] engagements


"$CGEM finds its new purpose in FLT3 #ASH25 https://www.oncologypipeline.com/apexonco/ash-2025-cullinan-finds-its-new-purpose-flt3 https://www.oncologypipeline.com/apexonco/ash-2025-cullinan-finds-its-new-purpose-flt3"  
[X Link](https://x.com/ApexOnco/status/1998400997811494994)  2025-12-09T14:35Z [----] followers, [----] engagements


"The ADC enthusiasm bypasses Mythic Therapeutics $ABBV https://www.oncologypipeline.com/apexonco/node/1808 https://www.oncologypipeline.com/apexonco/node/1808"  
[X Link](https://x.com/ApexOnco/status/2001635867358535703)  2025-12-18T12:49Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing